PT

Professor Triebel

Immutep Limited | Executive Director
Prof Triebel, was a Professor in Immunology at Paris University. While working at Institut Gustave Roussy (IGR), a cancer centre in Paris, he discovered the LAG-3 gene in 1990 and continued working on this research program since then, identifying the functions and medical usefulness of this molecule. He headed a research group at IGR while also being involved in the biological follow up of cancer patients treated in Phase I/II immunotherapy trials. He was Director of an INSERM Unit from 1991 to 1996. First trained as a clinical haematologist.

Company and Role

Company
Title
Tenure
Since
IMM
Immutep Limited
  • Executive Director
4yrs, 1mthSep 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
IMM
Immutep Limited
30/06/26N/A11,353,764N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
IMM
Immutep Limited
01/10/25
Issued
900,000$0.260$234,000Conversion of securities
IMM
Immutep Limited
01/10/25
Exercise
900,000$0.260$234,000Conversion of securities
IMM
Immutep Limited
03/04/25
Issued
1,800,000$0.260$468,000Conversion of securities
IMM
Immutep Limited
03/04/25
Exercise
1,800,000$0.260$468,000Conversion of securities
IMM
Immutep Limited
05/12/24
Issued
2,700,000$0.310$837,000Issue of securities